Idexx Laboratories Sustainability Profile
IDEXX Laboratories, Inc., a leading innovator in the veterinary diagnostics industry, is headquartered in the United States. Founded in 1983, the company has established itself as a key player in the development of diagnostic products and services for animal health, water testing, and dairy testing. With a strong presence in North America, Europe, and Asia, IDEXX is renowned for its advanced diagnostic technologies, including the IDEXX VetLab® suite and the SNAP® test platform. The company’s commitment to enhancing animal health and welfare is reflected in its core offerings, which include laboratory services, point-of-care diagnostics, and software solutions. IDEXX's unique approach combines cutting-edge technology with a deep understanding of veterinary needs, positioning it as a trusted partner in the industry. Notable achievements include a robust market share and recognition for its contributions to improving pet care and public health.
DitchCarbon Score
How does Idexx Laboratories's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Idexx Laboratories's score of 30 is higher than 50% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Idexx Laboratories's reported carbon emissions
In 2024, IDEXX Laboratories reported total greenhouse gas emissions of approximately 18,461,000 kg CO2e for Scope 1 and about 20,236,000 kg CO2e for Scope 2, resulting in combined emissions of around 38,697,000 kg CO2e. This marks an increase from 2023, where emissions were approximately 16,458,000 kg CO2e for Scope 1 and about 18,557,000 kg CO2e for Scope 2, totalling around 35,015,000 kg CO2e. IDEXX has set ambitious climate commitments, aiming to reduce its Scope 1 and 2 greenhouse gas emissions by 37.8% by 2030, with the baseline year being 2021. This target reflects the company's proactive approach to addressing climate change and aligns with industry standards for emissions reduction. The company has not disclosed any Scope 3 emissions data, indicating a focus primarily on direct and indirect emissions from its operations. IDEXX's emissions data is sourced directly from its own reporting, with no cascaded data from parent or related organisations. Overall, IDEXX Laboratories is actively working towards significant emissions reductions while maintaining transparency in its climate commitments.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - | - |
How Carbon Intensive is Idexx Laboratories's Industry?
How Carbon Intensive is Idexx Laboratories's Location?
Idexx Laboratories's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Idexx Laboratories has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Mindray Medical International Limited
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.